These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33857628)

  • 21. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
    Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
    J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
    Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
    J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
    Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
    Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DEAD-Box Helicase 17 exacerbates non-alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages.
    Ning D; Jin J; Fang Y; Du P; Yuan C; Chen J; Huang Q; Cheng K; Mo J; Xu L; Guo H; Yang MJ; Chen X; Liang H; Zhang B; Zhang W
    Clin Transl Med; 2024 Feb; 14(2):e1529. PubMed ID: 38303609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization.
    Jiang Q; Li Q; Liu B; Li G; Riedemann G; Gaitantzi H; Breitkopf-Heinlein K; Zeng A; Ding H; Xu K
    Int Immunopharmacol; 2021 Jul; 96():107591. PubMed ID: 33812253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress.
    Lee GR; Lee HI; Kim N; Lee J; Kwon M; Kang YH; Song HJ; Yeo CY; Jeong W
    J Cell Physiol; 2022 Sep; 237(9):3554-3564. PubMed ID: 35696549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
    Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1.
    Tang M; Cao H; Ma Y; Yao S; Wei X; Tan Y; Liu F; Peng Y; Fan N
    J Transl Med; 2024 Jul; 22(1):671. PubMed ID: 39033101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
    Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway.
    Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C
    Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-
    Hu J; Du H; Yuan Y; Guo P; Yang J; Yin X; Liu J; Wu S; Wan J; Gong X
    Mediators Inflamm; 2022; 2022():5791915. PubMed ID: 35769208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice.
    Yamaguchi K; Itoh Y; Yokomizo C; Nishimura T; Niimi T; Umemura A; Fujii H; Okanoue T; Yoshikawa T
    Lab Invest; 2011 Apr; 91(4):609-18. PubMed ID: 21321532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.